Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $129.9200 (-0.43%) ($128.3400 - $130.3600) on Fri. Jun. 16, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.62% (three month average) | RSI | 82 | Latest Price | $129.9200(-0.43%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR advances 3.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) IBB(44%) XLV(43%) XBI(42%) VT(39%) VYM(39%) | Factors Impacting UTHR price | UTHR will decline at least -0.81% in a week (0% probabilities). VIXM(-15%) TLT(-13%) UUP(-7%) TIP(-1%) SHY(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.81% (StdDev 1.62%) | Hourly BBV | 0 () | Intraday Trend | -0.2% | | | |
|
5 Day Moving Average | $130.63(-0.54%) | 10 Day Moving Average | $129.42(0.39%) | 20 Day Moving Average | $125.79(3.28%) | To recent high | -8.6% | To recent low | 9.8% | Market Cap | $5.763b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |